Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...

Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare regulations tighten and patient ...

Sleep apnea is a serious condition, causing breathing to stop and start several times during sleep. The most common form of the condition is obstructive sleep apnea, where the throat narrows, blocking ...

Q2 FY2026 earnings call recap: 11% revenue growth, margin expansion, AI innovation, and updated 62–63% guidance—read key takeaways now.

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

One large international study demonstrated that severe hypoxia during attempted intubation of critically ill patients occurs ...

RMD is set to report Q2 results on Jan. 29, with revenues likely to jump 8.3% and EPS 10.3% as masks, devices and software drive growth.

The arctic air gripping West Michigan can do more than just numb fingers and toes — it can also damage the upper respiratory ...

Jemma Jones hopes to inspire others to 'believe in themselves' enough to try losing weight naturally as more turn to jabs ...

Amid trashed valuations, investors await for signs of life for healthcare stocks in the February profit-reporting season. ...

Snoring is a bore - especially for anyone trying to sleep next to you - but could it be the sign of something more sinister?